Ignite Creation Date:
2025-12-24 @ 4:48 PM
Ignite Modification Date:
2026-01-24 @ 9:49 PM
Study NCT ID:
NCT03366350
Status:
UNKNOWN
Last Update Posted:
2019-05-10
First Post:
2017-12-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anti-CD19 CAR-T Therapy Bridging to HSCT for CD19+ B-Cell Malignancies
Sponsor:
Wuhan Sian Medical Technology Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04-15
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2017-12-01
First Submit QC Date:
None
Study First Post Date:
2017-12-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-08
Last Update Post Date:
2019-05-10
Last Update Post Date Type:
ACTUAL